TIMELY-PrädiktoR Prospective Study
Sponsor: Dr. Boris Schmitz
Trial Details
| Condition | Coronary Artery Disease |
| Status | Recruiting |
| Participants | 1,200 |
| Est. Completion | 31 Aug 2029 |
| Last Updated | 30 Mar 2026 |
Primary Outcome
Change in Cardiorespiratory Fitness (CRF); Change in risk of mortality; Number of patients with major adverse cardiac and cerebrovascular events (MACCE)
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: Coronary Artery Disease (CAD) patients after myocardial infarction (STEMI/NSTEMI) and/or angioplasty and/or Percutaneous Coronary Intervention (PCI) and/or coronary artery bypass graft surgery who participate in phase II Cardiac Rehabilitation (CR). Exclusion Criteria: * Incapability to give informed consent * Conditions that prevent patients from participation in CR including unstable coronary or cerebrovascular conditions and acute infections
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service